Patents by Inventor Sho Yamasaki

Sho Yamasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240159738
    Abstract: A new medical technique using follicular T cells is provided. The present disclosure is based on the finding of public TfhTCR which is specific to disease factors common to various patients, and provides a method for producing follicular T cells specific to a disease, including a step of identifying a disease-related factor or a part thereof having the ability to induce a follicular T cell reactive with the disease-related factor, a step of inducing the follicular T cell specific to the disease, by using the disease-related factor or a part thereof, and a step of obtaining the follicular T cell specific to the disease.
    Type: Application
    Filed: March 15, 2022
    Publication date: May 16, 2024
    Applicants: OSAKA UNIVERSITY, KOTAI Biotechnologies, Inc.
    Inventors: Sho Yamasaki, Xiuyuan Lu, Yuki Hosono, Shigenari Ishizuka, Kazuo Yamashita, Nicolas Claude Paul Sax
  • Publication number: 20240027656
    Abstract: A diffuser includes a lens array including multiple single lenses. Each of the multiple single lenses satisfies Expression (1), which contains a conic constant and represents an aspheric lens, and Expression (3), which defines a relationship between the conic constant k and the ratio r/D of a radius of curvature r of the single lens to a pitch D of the single lenses. A ray of light incident on the single lens and parallel to an optical axis of the single lens does not strike an edge part of the single lens.
    Type: Application
    Filed: December 22, 2021
    Publication date: January 25, 2024
    Applicant: KYOCERA Corporation
    Inventor: Sho YAMASAKI
  • Publication number: 20230139366
    Abstract: The invention relates to brartemicin analogues of Formula IV and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
    Type: Application
    Filed: October 19, 2022
    Publication date: May 4, 2023
    Inventors: Amy Jane FOSTER, Bridget Louise Stocker, Mattheus Simon Maria Timmer, Sho Yamasaki
  • Publication number: 20220412967
    Abstract: The present invention provides a method for capturing a candidate substance that can bind to a complex of a MR1 protein and a ?2 microglobulin protein more widely. A method for capturing a candidate substance that can bind to a complex of a MR1 protein and a ?2 microglobulin protein of the present invention includes steps of: forming a complex of the test substance, the MR1 protein, and the ?2 microglobulin protein by causing the test substance, the MR1 protein, and the ?2 microglobulin protein to coexist; and reducing the complex with a reducing agent.
    Type: Application
    Filed: November 16, 2020
    Publication date: December 29, 2022
    Inventors: Chihiro MOTOZONO, Sho YAMASAKI
  • Publication number: 20220396475
    Abstract: Provided is a cover member for an electronic device, the cover member having a through hole extending between a first surface and a second surface. The cover member for an electronic device includes a plurality of long particles that are present in an inner wall facing the through hole and whose longitudinal direction is along a through axis of the through hole in a cross section including the through axis.
    Type: Application
    Filed: September 24, 2020
    Publication date: December 15, 2022
    Applicant: KYOCERA Corporation
    Inventor: Sho YAMASAKI
  • Patent number: 11510980
    Abstract: The invention relates to brartemicin analogues of Formula (IV) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: November 29, 2022
    Assignees: VICTORIA LINK LTD., OSAKA UNIVERSITY
    Inventors: Amy Jane Foster, Bridget Louise Stocker, Mattheus Simon Maria Timmer, Sho Yamasaki
  • Publication number: 20210359492
    Abstract: An optical element mounting package includes a base. The base has a recess and a heat radiating portion. The recess includes a first mounting portion and a second mounting portion. On the first mounting portion, an optical element is mountable, and on the second mounting portion, an optical component is mountable. The heat radiating portion is located opposite the second mounting portion with the first mounting portion in between.
    Type: Application
    Filed: October 18, 2019
    Publication date: November 18, 2021
    Applicant: KYOCERA Corporation
    Inventors: Akihiko KITAGAWA, Sho YAMASAKI
  • Publication number: 20210177965
    Abstract: The invention relates to brartemicin analogues of Formula (IV) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
    Type: Application
    Filed: November 2, 2018
    Publication date: June 17, 2021
    Inventors: Amy Jane FOSTER, Bridget Louise STOCKER, Mattheus Simon Maria TIMMER, Sho YAMASAKI
  • Patent number: 8440187
    Abstract: Provided are a novel means for regulating inflammatory reactions by regulating the signaling in inflammatory responses caused by non-homeostatic cell death, specifically an anti-inflammatory agent comprising a substance that inhibits the expression of Mincle or the interaction of Mincle and SAP130 or FcR?, a screening method for a substance that regulates inflammatory reactions, comprising contacting Mincle or a fragment containing an extracellular region thereof and SAP130 in the presence and absence of a test substance, and comparing the degrees of the interaction of Mincle or the fragment thereof and SAP130 under the two conditions, a method of detecting non-homeostatic cell death, comprising measuring the amount of SAP130 in a sample collected from a subject animal, and the like.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: May 14, 2013
    Assignee: Riken
    Inventors: Takashi Saito, Sho Yamasaki
  • Publication number: 20110177084
    Abstract: Provided are a novel means for regulating inflammatory reactions by regulating the signaling in inflammatory responses caused by non-homeostatic cell death, specifically an anti-inflammatory agent comprising a substance that inhibits the expression of Mincle or the interaction of Mincle and SAP130 or FcR?, a screening method for a substance that regulates inflammatory reactions, comprising contacting Mincle or a fragment containing an extracellular region thereof and SAP130 in the presence and absence of a test substance, and comparing the degrees of the interaction of Mincle or the fragment thereof and SAP130 under the two conditions, a method of detecting non-homeostatic cell death, comprising measuring the amount of SAP130 in a sample collected from a subject animal, and the like.
    Type: Application
    Filed: July 17, 2009
    Publication date: July 21, 2011
    Applicant: RIKEN
    Inventors: Takashi Saito, Sho Yamasaki